For: | Sempokuya T, Forlemu A, Azawi M, Silangcruz K, Khoury N, Ma J, Wong LL. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World J Clin Oncol 2022; 13(5): 352-365 [PMID: 35662983 DOI: 10.5306/wjco.v13.i5.352] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i5/352.htm |
Number | Citing Articles |
1 |
Travis Zack, Kurt P. Losert, Samantha M. Maisel, Jennifer Wild, Amin Yaqubie, Michael Herman, Jennifer J. Knox, Robert J. Mayer, Alan P. Venook, Atul Butte, Allison F. O’Neill, Ghassan K. Abou-Alfa, John D. Gordan. Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data. npj Precision Oncology 2023; 7(1) doi: 10.1038/s41698-023-00371-2
|
2 |
Bengi Öztürk. Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas. Cureus 2023; doi: 10.7759/cureus.50795
|
3 |
S. K. Daniel, K. M. Sullivan, L. K. Dickerson, R. J. E. van den Bijgaart, A. F. Utria, K. P. Labadie, H. L. Kenerson, X. Jiang, K. S. Smythe, J. S. Campbell, R. H. Pierce, T. S. Kim, K. J. Riehle, R. S. Yeung, J. A. Carter, K. C. Barry, V. G. Pillarisetty. Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55593-6
|
4 |
Hassan Aziz, Zachary J Brown, Seyedeh Panid Madani, Ihab R Kamel, Timothy M Pawlik. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management. Journal of the American College of Surgeons 2023; 236(2): 399 doi: 10.1097/XCS.0000000000000476
|